Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (81-90 of 471) with videos related to

Pageof 48
Sort By:
Cancer|December 22, 2005
Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring systemDavid Dingli, Susan M Schwager, Ruben A Mesa, et al.
The Journal of Gene Medicine|September 28, 2012
Monitoring the initial delivery of an oncolytic measles virus encoding the human sodium iodide symporter to solid tumors using contrast-enhanced computed tomographyAlan R Penheiter, David Dingli, Claire E Bender, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 23, 2005
Focal and segmental glomerulosclerosis and plasma cell proliferative disordersDavid Dingli, Dirk R Larson, Matthew F Plevak, et al.
Cancer Research|August 18, 2018
<i>In Vivo</i> Estimation of Oncolytic Virus Populations within TumorsMi-Yeon Jung, Chetan P Offord, Matthew K Ennis, et al.
Rare Tumors|December 9, 2010
Angiomatoid fibrous histiocytoma in a 25-year-old maleAaron Mansfield, Brenda Larson, Scott L Stafford, et al.
Hematology Reports|November 25, 2024
Real-World Study of US Adults with Paroxysmal Nocturnal Hemoglobinuria Treated with PegcetacoplanBrian Mulherin, Apeksha Shenoy, Lily Arnett, et al.
Muscle & Nerve|April 25, 2025
Twenty Years Later, "AL Amyloidoma" Not "Non-Mutated ApoA1": Enhanced Diagnosis Through Mass Spectrometry AdvancementTony Zhang, David Dingli, David L Murry, et al.
Biochemical and Biophysical Research Communications|November 4, 2004
Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporterDavid Dingli, Elizabeth R Bergert, Zeljko Bajzer, et al.
Cancer|March 29, 2006
Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosisDavid Dingli, Susan M Schwager, Ruben A Mesa, et al.
Blood|March 22, 2003
Genetically targeted radiotherapy for multiple myelomaDavid Dingli, Rosa Maria Diaz, Elizabeth R Bergert, et al.
Pageof 48

Showing results (81-90 of 471) with videos related to

Sort By:
Pageof 48
Cancer|December 22, 2005
Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring systemDavid Dingli, Susan M Schwager, Ruben A Mesa, et al.
The Journal of Gene Medicine|September 28, 2012
Monitoring the initial delivery of an oncolytic measles virus encoding the human sodium iodide symporter to solid tumors using contrast-enhanced computed tomographyAlan R Penheiter, David Dingli, Claire E Bender, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 23, 2005
Focal and segmental glomerulosclerosis and plasma cell proliferative disordersDavid Dingli, Dirk R Larson, Matthew F Plevak, et al.
Cancer Research|August 18, 2018
<i>In Vivo</i> Estimation of Oncolytic Virus Populations within TumorsMi-Yeon Jung, Chetan P Offord, Matthew K Ennis, et al.
Rare Tumors|December 9, 2010
Angiomatoid fibrous histiocytoma in a 25-year-old maleAaron Mansfield, Brenda Larson, Scott L Stafford, et al.
Hematology Reports|November 25, 2024
Real-World Study of US Adults with Paroxysmal Nocturnal Hemoglobinuria Treated with PegcetacoplanBrian Mulherin, Apeksha Shenoy, Lily Arnett, et al.
Muscle & Nerve|April 25, 2025
Twenty Years Later, "AL Amyloidoma" Not "Non-Mutated ApoA1": Enhanced Diagnosis Through Mass Spectrometry AdvancementTony Zhang, David Dingli, David L Murry, et al.
Biochemical and Biophysical Research Communications|November 4, 2004
Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporterDavid Dingli, Elizabeth R Bergert, Zeljko Bajzer, et al.
Cancer|March 29, 2006
Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosisDavid Dingli, Susan M Schwager, Ruben A Mesa, et al.
Blood|March 22, 2003
Genetically targeted radiotherapy for multiple myelomaDavid Dingli, Rosa Maria Diaz, Elizabeth R Bergert, et al.
Pageof 48